• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞毒性颗粒相关 CD8+ T 细胞免疫在人天花小鼠模型中对快速保护性疫苗接种的关键作用。

Critical role of perforin-dependent CD8+ T cell immunity for rapid protective vaccination in a murine model for human smallpox.

机构信息

Institute for Infectious Diseases and Zoonoses, University of Munich LMU, Munich, Germany.

出版信息

PLoS Pathog. 2012;8(3):e1002557. doi: 10.1371/journal.ppat.1002557. Epub 2012 Mar 1.

DOI:10.1371/journal.ppat.1002557
PMID:22396645
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3291617/
Abstract

Vaccination is highly effective in preventing various infectious diseases, whereas the constant threat of new emerging pathogens necessitates the development of innovative vaccination principles that also confer rapid protection in a case of emergency. Although increasing evidence points to T cell immunity playing a critical role in vaccination against viral diseases, vaccine efficacy is mostly associated with the induction of antibody responses. Here we analyze the immunological mechanism(s) of rapidly protective vaccinia virus immunization using mousepox as surrogate model for human smallpox. We found that fast protection against lethal systemic poxvirus disease solely depended on CD4 and CD8 T cell responses induced by vaccination with highly attenuated modified vaccinia virus Ankara (MVA) or conventional vaccinia virus. Of note, CD4 T cells were critically required to allow for MVA induced CD8 T cell expansion and perforin-mediated cytotoxicity was a key mechanism of MVA induced protection. In contrast, selected components of the innate immune system and B cell-mediated responses were fully dispensable for prevention of fatal disease by immunization given two days before challenge. In conclusion, our data clearly demonstrate that perforin-dependent CD8 T cell immunity plays a key role in MVA conferred short term protection against lethal mousepox. Rapid induction of T cell immunity might serve as a new paradigm for treatments that need to fit into a scenario of protective emergency vaccination.

摘要

疫苗接种在预防各种传染病方面非常有效,而新出现的病原体的持续威胁需要开发创新的疫苗接种原则,以便在紧急情况下提供快速保护。尽管越来越多的证据表明 T 细胞免疫在预防病毒疾病方面发挥着关键作用,但疫苗的功效主要与抗体反应的诱导有关。在这里,我们使用小鼠痘作为人类天花的替代模型,分析了快速保护性痘苗病毒免疫的免疫学机制。我们发现,使用高度减毒的改良安卡拉痘苗病毒(MVA)或常规痘苗病毒进行疫苗接种,可快速有效地预防致死性全身性痘病毒病,仅依赖于 CD4 和 CD8 T 细胞反应。值得注意的是,CD4 T 细胞对于允许 MVA 诱导的 CD8 T 细胞扩增至关重要,而穿孔素介导的细胞毒性是 MVA 诱导保护的关键机制。相比之下,在挑战前两天进行免疫接种时,先天免疫系统的某些成分和 B 细胞介导的反应对于预防致命疾病是完全不需要的。总之,我们的数据清楚地表明,依赖于穿孔素的 CD8 T 细胞免疫在 MVA 诱导的短期保护中发挥了关键作用,针对致死性小鼠痘。快速诱导 T 细胞免疫可能成为一种新的治疗范例,这种治疗需要适应保护性紧急疫苗接种的情况。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e40d/3291617/aa591246c5e5/ppat.1002557.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e40d/3291617/a873492392ba/ppat.1002557.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e40d/3291617/2793c20fa98b/ppat.1002557.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e40d/3291617/b59b4791fcd3/ppat.1002557.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e40d/3291617/0be3e55bed4c/ppat.1002557.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e40d/3291617/fd2c65aba3bf/ppat.1002557.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e40d/3291617/eb60579d932f/ppat.1002557.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e40d/3291617/1962236046fb/ppat.1002557.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e40d/3291617/aa591246c5e5/ppat.1002557.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e40d/3291617/a873492392ba/ppat.1002557.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e40d/3291617/2793c20fa98b/ppat.1002557.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e40d/3291617/b59b4791fcd3/ppat.1002557.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e40d/3291617/0be3e55bed4c/ppat.1002557.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e40d/3291617/fd2c65aba3bf/ppat.1002557.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e40d/3291617/eb60579d932f/ppat.1002557.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e40d/3291617/1962236046fb/ppat.1002557.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e40d/3291617/aa591246c5e5/ppat.1002557.g008.jpg

相似文献

1
Critical role of perforin-dependent CD8+ T cell immunity for rapid protective vaccination in a murine model for human smallpox.细胞毒性颗粒相关 CD8+ T 细胞免疫在人天花小鼠模型中对快速保护性疫苗接种的关键作用。
PLoS Pathog. 2012;8(3):e1002557. doi: 10.1371/journal.ppat.1002557. Epub 2012 Mar 1.
2
Rapid expansion of CD8+ T cells in wild-type and type I interferon receptor-deficient mice correlates with protection after low-dose emergency immunization with modified vaccinia virus Ankara.野生型和I型干扰素受体缺陷型小鼠中CD8 + T细胞的快速扩增与用安卡拉痘苗病毒进行低剂量紧急免疫后的保护作用相关。
J Virol. 2014 Sep;88(18):10946-57. doi: 10.1128/JVI.00945-14. Epub 2014 Jul 9.
3
E3L and F1L Gene Functions Modulate the Protective Capacity of Modified Vaccinia Virus Ankara Immunization in Murine Model of Human Smallpox.E3L 和 F1L 基因功能调节改良安卡拉牛痘病毒免疫在人类天花小鼠模型中的保护效力。
Viruses. 2018 Jan 4;10(1):21. doi: 10.3390/v10010021.
4
Modified vaccinia virus Ankara immunization protects against lethal challenge with recombinant vaccinia virus expressing murine interleukin-4.安卡拉改良痘苗病毒免疫可保护机体免受表达小鼠白细胞介素-4的重组痘苗病毒的致死性攻击。
J Virol. 2004 Nov;78(22):12471-9. doi: 10.1128/JVI.78.22.12471-12479.2004.
5
Postexposure immunization with modified vaccinia virus Ankara or conventional Lister vaccine provides solid protection in a murine model of human smallpox.用安卡拉改良痘苗病毒或传统李斯特疫苗进行暴露后免疫接种,在人类天花的小鼠模型中可提供可靠的保护。
J Infect Dis. 2009 Jan 1;199(1):39-48. doi: 10.1086/595565.
6
Enhancement of CD8+ T cell immunity in the lung by CpG oligodeoxynucleotides increases protective efficacy of a modified vaccinia Ankara vaccine against lethal poxvirus infection even in a CD4-deficient host.CpG 寡脱氧核苷酸增强肺部 CD8+ T 细胞免疫,即使在 CD4 缺陷宿主中,也能提高改良安卡拉痘苗病毒疫苗对致死性痘病毒感染的保护效力。
J Immunol. 2006 Nov 1;177(9):6336-43. doi: 10.4049/jimmunol.177.9.6336.
7
Enhanced immunogenicity and protective effect conferred by vaccination with combinations of modified vaccinia virus Ankara and licensed smallpox vaccine Dryvax in a mouse model.在小鼠模型中,用改良安卡拉痘苗病毒和已获许可的天花疫苗Dryvax联合接种所赋予的增强免疫原性和保护作用。
Virology. 2005 Sep 1;339(2):164-75. doi: 10.1016/j.virol.2005.06.002.
8
Identification of vaccinia virus epitope-specific HLA-A*0201-restricted T cells and comparative analysis of smallpox vaccines.痘苗病毒表位特异性HLA - A*0201限制性T细胞的鉴定及天花疫苗的比较分析
Proc Natl Acad Sci U S A. 2003 Jan 7;100(1):217-22. doi: 10.1073/pnas.262668999. Epub 2002 Dec 23.
9
Protection against lethal vaccinia virus challenge in HLA-A2 transgenic mice by immunization with a single CD8+ T-cell peptide epitope of vaccinia and variola viruses.通过用痘苗病毒和天花病毒的单个CD8 + T细胞肽表位进行免疫接种,保护HLA - A2转基因小鼠免受致死性痘苗病毒攻击。
J Virol. 2004 Jul;78(13):7052-60. doi: 10.1128/JVI.78.13.7052-7060.2004.
10
Long term recall of memory CD8 T cells in mice to first and third generation smallpox vaccines.长期记忆 CD8 T 细胞在小鼠中对第一代和第三代天花疫苗的反应。
Vaccine. 2011 Feb 11;29(8):1666-76. doi: 10.1016/j.vaccine.2010.12.036. Epub 2010 Dec 31.

引用本文的文献

1
Efficacy of emergency maternal MVA-ZIKV vaccination in a rapid challenge model of lethal Zika infection.在致死性寨卡病毒感染快速攻击模型中,孕妇紧急接种MVA-ZIKV疫苗的效果。
NPJ Vaccines. 2025 Mar 5;10(1):44. doi: 10.1038/s41541-025-01094-0.
2
Equivalence of freeze-dried and liquid-frozen formulations of MVA-BN as smallpox and mpox vaccine.MVA-BN 的冻干和液冻制剂作为天花和猴痘疫苗的等效性。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2384189. doi: 10.1080/21645515.2024.2384189. Epub 2024 Aug 22.
3
Single MVA-SARS-2-ST/N Vaccination Rapidly Protects K18-hACE2 Mice against a Lethal SARS-CoV-2 Challenge Infection.

本文引用的文献

1
Gamma interferon and perforin control the strength, but not the hierarchy, of immunodominance of an antiviral CD8+ T cell response.γ干扰素和穿孔素控制抗病毒 CD8+T 细胞应答免疫优势的强度,但不控制其等级。
J Virol. 2011 Dec;85(23):12578-84. doi: 10.1128/JVI.05334-11. Epub 2011 Sep 14.
2
Safety and immunogenicity of two freeze-dried Vero cell rabies vaccines for human use in post-exposure prophylaxis.两种冻干vero 细胞狂犬病疫苗用于人接触后预防的安全性和免疫原性。
Vaccine. 2011 Mar 24;29(15):2679-81. doi: 10.1016/j.vaccine.2011.01.053. Epub 2011 Feb 3.
3
N1L is an ectromelia virus virulence factor and essential for in vivo spread upon respiratory infection.
单次 MVA-SARS-2-ST/N 疫苗接种可迅速保护 K18-hACE2 小鼠免受致死性 SARS-CoV-2 挑战感染。
Viruses. 2024 Mar 8;16(3):417. doi: 10.3390/v16030417.
4
Newly Designed Poxviral Promoters to Improve Immunogenicity and Efficacy of MVA-NP Candidate Vaccines against Lethal Influenza Virus Infection in Mice.新设计的痘病毒启动子可提高MVA-NP候选疫苗对小鼠致命性流感病毒感染的免疫原性和效力。
Pathogens. 2023 Jun 23;12(7):867. doi: 10.3390/pathogens12070867.
5
Protective CD8+ T Cell Response Induced by Modified Vaccinia Virus Ankara Delivering Ebola Virus Nucleoprotein.由安卡拉痘苗病毒携带埃博拉病毒核蛋白诱导的保护性CD8 + T细胞反应。
Vaccines (Basel). 2022 Mar 29;10(4):533. doi: 10.3390/vaccines10040533.
6
B cell depletion impairs vaccination-induced CD8 T cell responses in a type I interferon-dependent manner.B 细胞耗竭以依赖 I 型干扰素的方式损害疫苗诱导的 CD8 T 细胞应答。
Ann Rheum Dis. 2021 Dec;80(12):1537-1544. doi: 10.1136/annrheumdis-2021-220435. Epub 2021 Jul 5.
7
Microarray patches enable the development of skin-targeted vaccines against COVID-19.微阵列贴片可用于开发针对 COVID-19 的皮肤靶向疫苗。
Adv Drug Deliv Rev. 2021 Apr;171:164-186. doi: 10.1016/j.addr.2021.01.022. Epub 2021 Feb 2.
8
A Soluble Version of Nipah Virus Glycoprotein G Delivered by Vaccinia Virus MVA Activates Specific CD8 and CD4 T Cells in Mice.由痘苗病毒MVA递送的尼帕病毒糖蛋白G的可溶性版本可激活小鼠体内特异性CD8和CD4 T细胞。
Viruses. 2019 Dec 24;12(1):26. doi: 10.3390/v12010026.
9
Skin immunisation activates an innate lymphoid cell-monocyte axis regulating CD8 effector recruitment to mucosal tissues.皮肤免疫激活先天淋巴细胞-单核细胞轴,调节 CD8 效应细胞向黏膜组织的募集。
Nat Commun. 2019 May 17;10(1):2214. doi: 10.1038/s41467-019-09969-2.
10
Challenges and Achievements in Prevention and Treatment of Smallpox.天花预防与治疗中的挑战与成就
Vaccines (Basel). 2018 Jan 29;6(1):8. doi: 10.3390/vaccines6010008.
N1L 是一种细小病毒的毒力因子,对于呼吸道感染时的体内传播是必需的。
J Virol. 2011 Apr;85(7):3557-69. doi: 10.1128/JVI.01191-10. Epub 2011 Jan 26.
4
Age-dependent susceptibility to a viral disease due to decreased natural killer cell numbers and trafficking.由于自然杀伤细胞数量和迁移减少导致的病毒疾病的年龄依赖性易感性。
J Exp Med. 2010 Oct 25;207(11):2369-81. doi: 10.1084/jem.20100282. Epub 2010 Sep 27.
5
First-in-human clinical trials with vaccines--what regulators want.人体首次临床试验中的疫苗——监管机构的期望。
Nat Biotechnol. 2010 Sep;28(9):910-6. doi: 10.1038/nbt0910-910.
6
Concomitant type I IFN receptor-triggering of T cells and of DC is required to promote maximal modified vaccinia virus Ankara-induced T-cell expansion.需要同时激活 T 细胞和 DC 的 I 型干扰素受体,以促进最大程度的改良安卡拉痘苗病毒诱导的 T 细胞扩增。
Eur J Immunol. 2010 Oct;40(10):2769-77. doi: 10.1002/eji.201040453.
7
Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of Congo.刚果民主共和国停止天花疫苗接种活动 30 年后,人类猴痘发病率大幅上升。
Proc Natl Acad Sci U S A. 2010 Sep 14;107(37):16262-7. doi: 10.1073/pnas.1005769107. Epub 2010 Aug 30.
8
Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation.采用 pp65 特异性 T 细胞进行过继转移治疗亲缘单倍体和非亲缘无关干细胞移植后发生的化学抵抗性巨细胞病毒病或再激活。
Blood. 2010 Nov 18;116(20):4360-7. doi: 10.1182/blood-2010-01-262089. Epub 2010 Jul 12.
9
Evaluation of cytomegalovirus (CMV)-specific T cell immune reconstitution revealed that baseline antiviral immunity, prophylaxis, or preemptive therapy but not antithymocyte globulin treatment contribute to CMV-specific T cell reconstitution in kidney transplant recipients.评估巨细胞病毒 (CMV)-特异性 T 细胞免疫重建表明,基线抗病毒免疫、预防或抢先治疗,但不是抗胸腺细胞球蛋白治疗有助于肾移植受者的 CMV 特异性 T 细胞重建。
J Infect Dis. 2010 Aug 15;202(4):585-94. doi: 10.1086/654931.
10
Immune requirements of post-exposure immunization with modified vaccinia Ankara of lethally infected mice.感染致死剂量的改良安卡拉牛痘后暴露后免疫的免疫要求。
PLoS One. 2010 Mar 11;5(3):e9659. doi: 10.1371/journal.pone.0009659.